Boston, MA (PRWEB) February 21, 2014
The National Patient Safety Foundation (NPSF), a central voice for patient safety since 1997, is pleased to announce that Pacira Pharmaceuticals, Inc., has joined the NPSF Patient Safety Coalition as an associate member. Pacira, located in New Jersey and California, is a specialty pharmaceutical company focused on the development of new products for the acute care setting.
“Pacira has long held a commitment to quality,” said Dave Stack, president, chief executive officer, and chairman of Pacira. “We look forward to working with the National Patient Safety Foundation and our fellow Coalition members in pursuing a safer health care system.”
Membership in the NPSF Patient Safety Coalition is open to solutions providers that are working to address patient safety challenges, professional associations, advocacy organizations, and others. Joining the Coalition provides unique opportunities for networking, learning, and knowledge sharing through quarterly conference calls, an annual member meeting, and periodic webinars.
“Members of the NPSF Patient Safety Coalition share the Foundation’s mission of advancing the delivery of safe health care across the continuum,” said Tejal K. Gandhi, MD, MPH, CPPS, president of NPSF. “We are very pleased to recognize this commitment from Pacira, and we look forward to working with them to share knowledge and promote innovations in the field.”
For more information about the NPSF Patient Safety Coalition and how to join, contact David Coletta, senior vice president, at dcoletta(at)npsf(dot)org.
About the National Patient Safety Foundation
The National Patient Safety Foundation’s vision is to create a world where patients and those who care for them are free from harm. A central voice for patient safety since 1997, NPSF partners with patients and families, the health care community, and key stakeholders to advance patient safety and health care workforce safety and disseminate strategies to prevent harm. NPSF is an independent, not-for-profit 501(c)(3) organization. To learn more about the Foundation's work, visit http://www.npsf.org.
Pacira Pharmaceuticals, Inc., is a specialty pharmaceutical company focused on the clinical and commercial development of new products that meet the needs of acute care practitioners and their patients. The company’s current emphasis is the development of non-opioid products for postsurgical pain control, and its lead product, EXPAREL® (bupivacaine liposome injectable suspension), was commercially launched in the United States in April 2012. EXPAREL and two other products have utilized the Pacira proprietary product delivery technology DepoFoam®, a unique platform that encapsulates drugs without altering their molecular structure and then releases them over a desired period of time. Additional information about Pacira is available at http://www.pacira.com.